Nice announcement with US and European registration of the own branded cryovials, and the market seems to have liked it too with shares up over 20%. Now to see how this plays out and if they can continue to execute.

For those that are not aware, the company plays in the cryogenic space. The business produces identification tags to ensure tracking and provides confidence. This tech is backed by multiple global patents. The product has been sold to OEM in IVF, and cryogenic consumables (biobanking).

This is a narrow, but important industry with an ever-increasing focus on health, and with a world becoming more and more litigious.

The company is not sitting on their hand and is looking at other aligned cold storage and cold logistics applications in health care.

They seem to have gotten out/ over the Labcon litigation which also removes a real risk.

Currently sitting on 6M cash but burning around 1M per quarter.

Not held, but on the watchlist. 

A nice announcement and subsequent move in BTC Bluechip today. I just went to have a look at how many Straw peeps hold it, Only 2! Myself and my mate Dafish.

Talk about being under the radar. It's still only 42million market cap after todays move.

Bluechiip Enabled Products registered with (US) FDA and (EU) CE IVD certified

Bluechiip Limited [ASX: BCT], a leader in the development of advanced sample management solutions for harsh environments, today announced the recent registration of Bluechiip’s own branded cryovials with the United States FDA (USA) and receipt of the European CE IVD certification.

These important US and EU certifications enable the company to directly sell into these key target margets.

The company has now globaly launched its Bluechiip-Enabled sample management solutions product line, including Sample Storage consumables, Readers, and StreamTM Sample Management Software.

The company plans to market and sell the Bluechiip-Enabled product line directly into North America and Australia/New Zealand and through distribution partners across European and Asia Pacific markets.